This drug has three hundred and forty-seven patent family members in forty-nine countries.
The generic ingredient in SOLIQUA 100/33 is insulin glargine; lixisenatide. One supplier is listed for this compound. Additional details are available on the insulin glargine; lixisenatide profile page.
Copyright © DrugPatentWatch. Originally published at New patent for Sanofi-aventis Us drug SOLIQUA 100/33